Allison Ciaccio had a respiratory illness that wouldn't go away. Repeated follow-ups found Stage I lung cancer.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, Zuckerman Institute, and Irving Institute for Cancer Dynamics, along with ...

Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs. wedge resection, according to results presented at the Society of Thoracic ...

Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...

Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help ...

According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years. Overall, though, the news ...

Air pollution doesn’t just stop at irritating your lungs, it can lead to serious heart and lung diseases. Let’s understand everything about air pollution and its effects on lungs and heart, so you can ...

Research is still in the early stages of how vaping affects lungs – but worrying conditions, like ‘popcorn lung’, are on the rise. Dr Stephen Broderick, of John Hopkins Medicine, has now ...

Today (TBC) Australian researchers reveal how multiple chemicals found in cigarette smoke and e-cigarettes alter the function of a key type of immune cell found in the lungs. Cigarette smoking is ...

Delhi residents are exposed to 10-18 million nanoparticles daily, with roadside deposits 30% higher, posing severe health risks due to deeper lung penetration and bloodstream impact. The research ...

BBO-8520, an investigational oral agent, has been granted fast track designation from the FDA in previously treated KRAS G12C–mutated metastatic non–small cell lung cancer. The FDA has granted ...